Concepedia

S Neben

SN

32

Publications

2.4K

Citations

24

H-Index

1988

Active since

Affiliations

Regulus Therapeutics (United States)(Current)

Erasmus University Rotterdam

The University of Osaka

Harvard University

University Medical Center Groningen

S Neben is an author at Regulus Therapeutics (United States) specializing in medicine, cell biology, and immunology.

Top concepts

Publications per year

1988–2022

32

Publications

32

Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial

Meike H. van der Ree, J. Marleen de Vree, F. Stelma et al. · The Lancet · 2017 · 259 citations

, , +7

Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay.

Dimitri Breems, EAW Blokland, S Neben et al. · PubMed · 1994 · 242 citations

Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease

Edmund C. Lee, Tania Valencia, Charles Allerson et al. · Nature Communications · 2019 · 185 citations · Full text

Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease

Sunil Abhyankar, S Neben, G W Newman et al. · Blood · 1991 · 175 citations · Full text

Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor

S Neben, Karen J. Marcus, Peter Mauch · Blood · 1993 · 151 citations · Full text

Rows per page

1–5 of 32